Tumor Immunology and Immunotherapy

​October 1-4, 2017
Boston Marriott Copley Place
Boston, Massachusetts

Advance Registration Deadline: Friday, September 8​, 2017, 11:59 p.m. ET

Conference Cochairs
James P. Allison, The University of Texas MD Anderson Cancer Center, Houston, Texas
Carl H. June, University of Pennsylvania, Philadelphia, Pennsylvania
Miriam Merad, Icahn School of Medicine at Mount Sinai, New York, New York
Giorgio Trinchieri, National Cancer Institute, Bethesda, Maryland

The AACR Special Conference on Tumor Immunology and Immunotherapy will focus on recent advances in understanding the range of immune responses towards cancer and how these can be modified and harnessed for prevention and therapeutics. This year’s program will focus on mechanisms, models, and novel technologies, with talks on basic research and translational implications, all geared towards a deeper understanding of the immunologic science of the cancer cell in order to design better treatments. The conference will feature the world’s premier oncologists who will present their latest research on current immunotherapies, engineered cells, checkpoints, and combinations. In addition, highly acclaimed basic researchers and immunologists will help bridge the gap between the cutting-edge advances that are under way in the lab, such as single-cell analysis, neoantigens, systems and synthetic biology, and their application to clinical practice. Please join us to take part in these interactions and network with investigators in the field of tumor immunology and immunotherapy.

Lead Supporter

Bristol-Myers Squibb   



Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available